(MedPage Today) — ORLANDO — Adalimumab (Humira) was more effective than conventional immunosuppressive drugs at lowering or eliminating the need for corticosteroid use in patients with noninfectious uveitis, according to ADVISE trial data…
Source link : https://www.medpagetoday.com/meetingcoverage/aao/118022
Author :
Publish date : 2025-10-19 18:50:00
Copyright for syndicated content belongs to the linked Source.
